Literature DB >> 28486883

Monitoring of Optimal Cerebral Perfusion Pressure in Traumatic Brain Injured Patients Using a Multi-Window Weighting Algorithm.

Xiuyun Liu1, Natasha M Maurits2, Marcel J H Aries1,3, Marek Czosnyka1,4, Ari Ercole1, Joseph Donnelly1, Danilo Cardim1, Dong-Joo Kim5, Celeste Dias6, Manuel Cabeleira1, Peter Smielewski1.   

Abstract

Methods to identify an autoregulation guided "optimal" cerebral perfusion pressure (CPPopt) for traumatic brain injury patients (TBI) have been reported through several studies. An important drawback of existing methodology is that CPPopt can be calculated only in ∼50-60% of the monitoring time. In this study, we hypothesized that the CPPopt yield and the continuity can be improved significantly through application of a multi-window and weighting calculation algorithm, without adversely affecting preservation of its prognostic value. Data of 526 severe TBI patients admitted between 2003 and 2015 were studied. The multi-window CPPopt calculation was based on automated curve fitting in pressure reactivity index (PRx)-CPP plots using data from 36 increasing length time windows (2-8 h). The resulting matrix of CPPopts was then averaged in a weighted manner. The yield, continuity, and stability of CPPopt were studied. The difference between patients' actual CPP and CPPopt (ΔCPP) was calculated and the association with outcome was analyzed. Overall, the multi-window method demonstrated more continuous and stable presentation of CPPopt in this cohort. The new method resulted in a mean (±SE) CPPopt yield of 94% ± 2.1%, as opposed to the previous single-window-based CPPopt yield of 51% ± 0.94%. The stability of CPPopt across the whole monitoring period was significantly improved by using the new algorithm (p < 0.001). The relationship between ΔCPP according to the multi-window algorithm and outcome was similar to that for CPPopt calculated on the basis of a single window. In conclusion, this study validates the use of a new multi-window and weighting algorithm for significant improvement of CPPopt yield in TBI patients. This methodological improvement is essential for its clinical application in future CPPopt trials.

Entities:  

Keywords:  CPPopt; TBI; cerebral autoregulation; multi-window algorithm; pressure reactivity index

Mesh:

Year:  2017        PMID: 28486883     DOI: 10.1089/neu.2017.5003

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  13 in total

1.  Wavelet pressure reactivity index: a validation study.

Authors:  Xiuyun Liu; Marek Czosnyka; Joseph Donnelly; Danilo Cardim; Manuel Cabeleira; Peter J Hutchinson; Xiao Hu; Peter Smielewski; Ken Brady
Journal:  J Physiol       Date:  2018-06-13       Impact factor: 5.182

2.  Impact of Arterial Carbon Dioxide and Oxygen Content on Cerebral Autoregulation Monitoring Among Children Supported by ECMO.

Authors:  Nicolas Joram; Erta Beqiri; Stefano Pezzato; Moscatelli Andrea; Chiara Robba; Jean-Michel Liet; Alexis Chenouard; Pierre Bourgoin; Marek Czosnyka; Pierre-Louis Léger; Peter Smielewski
Journal:  Neurocrit Care       Date:  2021-03-09       Impact factor: 3.210

3.  Continuous Assessment of "Optimal" Cerebral Perfusion Pressure in Traumatic Brain Injury: A Cohort Study of Feasibility, Reliability, and Relation to Outcome.

Authors:  Andreas H Kramer; Philippe L Couillard; David A Zygun; Marcel J Aries; Clare N Gallagher
Journal:  Neurocrit Care       Date:  2019-02       Impact factor: 3.210

4.  Deviations from NIRS-derived optimal blood pressure are associated with worse outcomes after pediatric cardiac arrest.

Authors:  Matthew P Kirschen; Tanmay Majmudar; Forrest Beaulieu; Ryan Burnett; Mohammed Shaik; Ryan W Morgan; Wesley Baker; Tiffany Ko; Ramani Balu; Kenya Agarwal; Kristen Lourie; Robert Sutton; Todd Kilbaugh; Ramon Diaz-Arrastia; Robert Berg; Alexis Topjian
Journal:  Resuscitation       Date:  2021-09-29       Impact factor: 6.251

5.  Evaluation of a New Catheter for Simultaneous Intracranial Pressure Monitoring and Cerebral Spinal Fluid Drainage: A Pilot Study.

Authors:  Xiuyun Liu; Lara L Zimmermann; Nhi Ho; Paul Vespa; Xiaoling Liao; Xiao Hu
Journal:  Neurocrit Care       Date:  2019-06       Impact factor: 3.210

6.  Wavelet Autoregulation Monitoring Identifies Blood Pressures Associated With Brain Injury in Neonatal Hypoxic-Ischemic Encephalopathy.

Authors:  Xiuyun Liu; Aylin Tekes; Jamie Perin; May W Chen; Bruno P Soares; An N Massaro; Rathinaswamy B Govindan; Charlamaine Parkinson; Raul Chavez-Valdez; Frances J Northington; Ken M Brady; Jennifer K Lee
Journal:  Front Neurol       Date:  2021-04-28       Impact factor: 4.003

7.  Deviations from PRx-derived optimal blood pressure are associated with mortality after cardiac arrest.

Authors:  Matthew P Kirschen; Tanmay Majmudar; Ramon Diaz-Arrastia; Robert Berg; Benjamin S Abella; Alexis Topjian; Ramani Balu
Journal:  Resuscitation       Date:  2022-03-08       Impact factor: 6.251

8.  Optimal cerebral perfusion pressure via transcranial Doppler in TBI: application of robotic technology.

Authors:  Frederick A Zeiler; Marek Czosnyka; Peter Smielewski
Journal:  Acta Neurochir (Wien)       Date:  2018-09-29       Impact factor: 2.216

9.  Low-resolution pressure reactivity index and its derived optimal cerebral perfusion pressure in adult traumatic brain injury: a CENTER-TBI study.

Authors:  Lennart Riemann; Erta Beqiri; Peter Smielewski; Marek Czosnyka; Nino Stocchetti; Oliver Sakowitz; Klaus Zweckberger; Andreas Unterberg; Alexander Younsi
Journal:  Crit Care       Date:  2020-05-26       Impact factor: 9.097

10.  Feasibility of individualised severe traumatic brain injury management using an automated assessment of optimal cerebral perfusion pressure: the COGiTATE phase II study protocol.

Authors:  Erta Beqiri; Peter Smielewski; Chiara Robba; Marek Czosnyka; Manuel Teixeira Cabeleira; Jeanette Tas; Joseph Donnelly; Joanne G Outtrim; Peter Hutchinson; David Menon; Geert Meyfroidt; Bart Depreitere; Marcel J Aries; Ari Ercole
Journal:  BMJ Open       Date:  2019-09-20       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.